VolitionRx Limited
General ticker "VNRX" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $59.1M (TTM average)
VolitionRx Limited does not follow the US Stock Market performance with the rate: -1.7%.
Estimated limits based on current volatility of 4.7%: low 0.28$, high 0.31$
Factors to consider:
- Total employees count: 110 (+5.8%) as of 2023
- Top business risk factors: Lack of profitability, Need for additional capital, Market competition, Regulatory and compliance, Supply chain disruptions
- Current price 28.4% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.43$, 1.14$]
- 2025-12-31 to 2026-12-31 estimated range: [0.47$, 1.22$]
Financial Metrics affecting the VNRX estimates:
- Positive: with PPE of -2.0 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -48.20 <= 0.33
- Positive: Industry inventory ratio change (median), % of -0.79 <= -0.15
- Negative: negative Industry operating cash flow (median)
- Positive: -4.48 < Investing cash flow per share per price, % of -1.07
- Positive: Inventory ratio change, % of -3.63 <= -0.75
- Positive: Interest expense per share per price, % of 0.63 <= 0.79
Short-term VNRX quotes
Long-term VNRX plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.31MM | $0.78MM | $1.23MM |
| Operating Expenses | $32.09MM | $36.76MM | $28.26MM |
| Operating Income | $-31.78MM | $-35.99MM | $-27.02MM |
| Non-Operating Income | $1.18MM | $0.31MM | $-0.23MM |
| Interest Expense | $0.17MM | $0.22MM | $0.34MM |
| R&D Expense | $15.33MM | $19.55MM | $14.41MM |
| Income(Loss) | $-30.60MM | $-35.68MM | $-27.26MM |
| Profit(Loss)* | $-30.27MM | $-35.32MM | $-26.97MM |
| Stockholders Equity | $-3.13MM | $-7.80MM | $-24.91MM |
| Assets | $18.30MM | $27.95MM | $9.40MM |
| Operating Cash Flow | $-15.28MM | $-18.06MM | $-25.89MM |
| Capital expenditure | $1.57MM | $1.08MM | $0.57MM |
| Investing Cash Flow | $-1.57MM | $-1.08MM | $-0.57MM |
| Financing Cash Flow | $6.94MM | $28.98MM | $8.66MM |
| Earnings Per Share** | $-0.55 | $-0.50 | $-0.31 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.